Big news: First nasal vaccine against Covid 19 anytime soon

Phase 1 clinical trial completed in the 18-60 age group

By Jasleen Kaur - August 13, 2021 7:08 pm

The first intranasal vaccine against Covid 19, developed by Bharat Biotech, has received regulator’s nod for conducting phase 2 and 3 clinical trials, the Department of Biotechnology said on Friday.

Phase 1 clinical trial has been completed in the 18-60 age group, it said. “Bharat Biotech’s intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2/3 trials,” the DBT said.


-PTC News